Advent Technologies Holdings, Inc. (ADN)

$1.3 Billion All-Cash Transaction Heidrick Stockholders to Receive $59.00 per Share in Cash CHICAGO , Oct. 6, 2025 /PRNewswire/ -- Heidrick & Struggles International, Inc. (Nasdaq: HSII) ("Heidrick" or the "Company"), a premier global leadership advisor, today announced that it has entered into a definitive agreement whereby a consortium of investors led by Advent International ("Advent") and Corvex Private Equity ("Corvex"), and including several leading family offices, will acquire all of the Company's outstanding public shares. This new investor consortium will include significant investment from many Heidrick leaders.

LIVERMORE, Calif., Sept. 29, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: ADN) Advent Technologies Holdings, Inc., through its wholly owned subsidiary, Advent Technologies, SA, is pleased to announce a new contract with Siqens GmbH, a leading German fuel cell system manufacturer. Under the terms of the 12-month contract, Advent will supply Membrane Electrode Assemblies (“MEAs”) for integration into Siqens' innovative fuel cell systems.

BETHESDA, Md. , Aug. 27, 2025 /PRNewswire/ -- Northwest Biotherapeutics, Inc. (OTCQB:NWBO) (the "Company" or "NWBio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced that it has entered into an agreement to acquire Advent BioServices Ltd.

LIVERMORE, Calif., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Advent Technologies Holdings, Inc. (NASDAQ: ADN), an innovation driven leader in fuel cells and hydrogen technologies is pleased to announce that it has received an initial order for its Ion Pair High Temperature Proton Exchange Membrane electrode assemblies (“HT-PEM”) from one of the major players in the energy sector. With more than 50,000 employees in over 100 countries, this energy giant's technology is used to generate a large percentage of the world's electricity. It is actively pursuing new opportunities in the energy transition, including:

LIVERMORE, Calif., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Advent Technologies Holdings, Inc. (NASDAQ: ADN) an innovation-driven leader in the fuel cell and hydrogen technology sector, is supplying its proprietary membrane electrode assembly technology to Stralis Aircraft, based in Australia, for their hydrogen electric Beechcraft Bonanza aircraft.

The offer represents a 53% premium to U-blox's average share price over the six months through Aug. 14.

Switzerland's U-Blox said on Sunday it has entered into a transaction agreement with Advent International, via its European subsidiary ZI Zenith, for 1.05 billion Swiss francs ($1.30 billion).

Switzerland's U-Blox Holding , a maker of microchips and software for car navigation, said on Friday that it was in talks with Advent International about being taken over by the private equity firm.

Sapiens shareholders to receive $43.50 per share in cash, a 64% premium to Sapiens' undisturbed closing share price of $26.52 on August 8, 2025   KEY HIGHLIGHTS Sapiens shareholders will receive $43.50 per share in cash, representing a premium of approximately 64% over Sapiens' undisturbed closing share price of $26.52 on August 8, 2025. Transaction values Sapiens at approximately $2.5 billion.

LIVERMORE, Calif., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Advent Technologies Holdings, Inc. (NASDAQ: ADN), an innovation-driven company in the fuel cell and hydrogen technology space, announced today that it has entered into a new enhanced license agreement with TRIAD National Security for the Ion Pair technology originally developed at Los Alamos National Laboratory. In the new enhanced license, Advent acquired exclusivity to the technology in the marine, aviation, and portable power fields while retaining its non-exclusive rights in all other fields.

EDMUNDSTON, New Brunswick, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Acadian Timber Corp. (“Acadian” or the “Company”) (TSX:ADN) today reported financial and operating results1 for the three months ended June 28, 2025 (the “second quarter”).

Consumer insights company NIQ Global [NIQ.N], backed by investment firms Advent International and KKR , said on Tuesday it had raised $1.05 billion in its initial public offering in the United States.

In this episode of our Proactive Podcast, After Market, OTC Markets Group executive vice president Jason Paltrowitz joins us to discuss how international companies—especially those listed on the Australian Securities Exchange (ASX)—can efficiently expand their reach to United States investors through secondary trading on OTC Markets. Paltrowitz joined us last week to explain the challenges US investors face when trying to access equities listed on overseas exchanges such as the ASX, London Stock Exchange, or Euronext Paris. Paltrowitz outlined how OTC Markets bridges this gap by allowing companies to make their shares available in US dollars during US trading hours, through regulated trading platforms. The episode also explores OTC Markets’ tiered structure, with a focus on OTCQX—the “best market”—and OTCQB, the “venture market,” tailored for growth-stage companies. Over 80 ASX-listed companies are already leveraging these platforms. Paltrowitz introduces the “List Local, Trade Global” strategy, enabling firms to maintain their primary listings at home while gaining exposure to US liquidity—without the added burden of full US regulatory compliance such as SEC filing or Sarbanes-Oxley. The conversation concludes with a look at rising US investor interest in international equities—Asian and European trading volumes have surged—and previews upcoming innovations like overnight trading and the OTCID platform aimed at enhancing market access and transparency. Andromeda Metals Ltd (ASX:ADN, OTC:ANDMF)has received credit approval for a A$75 million debt facility from Merricks Capital to advance the development of its Great White Project in South Australia. The facility includes principal, interest, fees, reserves, and a cost overrun tranche and represents a key step toward finalising the Stage 1A+ development. Negotiations for binding financing documentation are now underway, with completion subject to standard conditions precedent including securing the balance of required funding. “Receiving confirmation from Merricks Capital that the proposed facility is credit approved, following extensive due diligence, represents a significant milestone in the financing of Stage 1A+ of the Great White Project,” acting chief executive officer Sarah Clarke said. “This outcome is a strong endorsement of the project’s quality and a testament to the team’s dedication, expertise and commitment to delivering an investment ready project.” The A$75 million facility carries a tenor of 78 months from financial close. Amortisation will begin after a 12-month grace period post-development completion, concluding with a 50% bullet repayment at maturity. Interest is payable on drawn funds, with line fees applied to undrawn amounts. Security and covenant conditions are aligned with conventional debt arrangements of this nature, including cover ratios and minimum cash balances. Should financial close be achieved and shareholder approvals granted, Merricks Capital is expected to receive 400 million equity warrants. These will be priced at a 10% premium to the share price in the balance of development funding and expire upon final facility repayment. The credit approval follows detailed due diligence by Merricks Capital across the technical, financial, legal, market, environmental and social aspects of the Great White Project. Pareto Securities acted as financial adviser during the process. With this milestone reached, Andromeda is now focused on securing additional funding required for a final investment decision and financial close, while continuing due diligence with selected capital providers. In late May, Andromeda secured A$5 million through a placement to institutional and sophisticated investors, bolstering its pathway to a FID for the Great White Project. Shares were issued at A$0.013 each. Proceeds from the raise have gone towards early works on the Great White Project, finalising plant design, and covering key legal, technical and financial due diligence activities required for project financing. Funds will also contribute to a scoping study for a potential high-purity alumina (HPA) project and provide general working capital. Read more: Andromeda Metals completes $5 million placement, sharpens focus on Great White and HPA Following the placement, Andromeda held approximately A$9.5 million in cash, enabling continued progress toward FID. MST Access senior analyst Michael Bentley described the Great White Project as “largely de-risked”, noting that most long-lead items have been secured, key permits granted and offtake agreements signed. “Final project funding is the key catalyst for a material re-rating,” Bentley said. He values Andromeda at A$0.13 per share, compared to its current price of around A$0.011. “We also believe that a cornerstone investor may well pay a premium to the current share price to take a significant share of the company,” Bentley added.

ATHENS, Greece and LIVERMORE, Calif., May 27, 2025 (GLOBE NEWSWIRE) -- Advent Technologies Holdings, Inc. (NASDAQ: ADN) ("Advent "or the "Company"), an innovation-driven leader in the fuel cell and hydrogen technology sector, is pleased to announce that Joseph Hosni has joined the Company as the Director of Commercial Sales. Mr. Hosni will be based at the Company's Athens office.

LIVERMORE, Calif., May 23, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: ADN) On May 22, 2025, Advent Technologies Holdings, Inc. (the “Company”) received a letter (the “Letter”) from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) notifying the Company that it is not in compliance with periodic requirements for continued listing set forth in Nasdaq Listing Rule 5250(c)(1) because the Company's Quarterly Report on Form 10-Q for the period ended March 31, 2025 was not filed with the Securities and Exchange Commission by the required due date of May 15, 2025, and because the Company's Annual Report on Form 10-K for the year ended December 31, 2024 was not filed by the required due date of March 31, 2025 and has not yet been filed. This Letter received from Nasdaq has no immediate effect on the listing or trading of the Company's shares.